Evidence map›Paper›PMID 30930665›Full record

ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

5-Fluorouracyl added infusion fluid in patients with recurrent rhegmatogeneous retinal detachment.

Muharrem Karakaya, Sinan Albayrak, Seren Pehlivanoglu, Abdullah Ozkaya, Nur Acar Gocgil

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Proliferative Vitreoretinopathy: A Reappraisal.Journal of clinical medicine · 2023
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Muharrem KarakayaDepartment of Ophthalmology, Yeniyuzyil University Medical Faculty, Istanbul, Turkey.
Sinan AlbayrakDepartment of Ophthalmology, Yeniyuzyil University Medical Faculty, Istanbul, Turkey.
Seren PehlivanogluDepartment of Ophthalmology, Yeniyuzyil University Medical Faculty, Istanbul, Turkey.
Abdullah OzkayaDepartment of Ophthalmology, Surp Pirgic Armenian Hospital, Istanbul, Turkey.
Nur Acar GocgilDepartment of Ophthalmology, Acibadem University Medical Faculty, Istanbul, Turkey.
Istanbul Yeni Yüzyıl University · TRAcıbadem University · TRYedikule Surp Pırgiç Ermeni Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the efficacy of 5-fluorouracil (5-FU) added the infusion fluid with a control group in the event of grade C PVR in recurrent retinal detachment (RD).

methodsThe records of the patients with recurrent retinal detachment with grade C PVR who underwent vitrectomy for retinal detachment surgery between April 2003 and October 2004 were reviewed retrospectively for this comparative study. The recurrent retinal detachment patients with grade C PVR who underwent vitrectomy and had a minimum post-operative follow-up period of 12 months were included. The patients were divided into two groups as study and control groups. 5-FU (200 microgram/ml) and low-molecular-weight-heparin (LMWH) (5 IU/ml) was added into the infusion solution of the study group. Primary outcome measure of this study was the single operation anatomical success at month 12.

resultsA total of 43 eyes of 43 patients were included. The control group was consisted of 26 eyes (60.5%) and the 5-FU group was consisted of 17 eyes (39.5%). At month 12, single operation anatomical success was obtained in 14 of the 26 patients (53.8%) in the control group and in 16 of the 17 patients (94.1%) in the 5-FU group (p = 0.005).

conclusionFavorable outcomes were obtained in the patients with recurrent RD and grade C PVR in whom 5-FU and LMWH added infusion fluid which was used during vitrectomy.

Indexed as

5-FluorouracilProliferative vitreoretinopathyRetinal detachmentVitrectomy

Identifiers

PMID30930665
PMCPMC6424708
OpenAlexW2898581409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.